drugset / Trial / NCT01185080
Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this study is to investigate effect, tolerability and safety of different dosing regimens of AZD8848 administered intranasally to seasonal allergic rhinitis patients out of season in an allergen challenge model.
Timeline
- Start
- 2010-09
- Primary completion
- 2010-12
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8848 | Small molecule | 20 ug | Intranasal |
| Subject | AZD8848 | Small molecule | 60 ug | Intranasal |